PHARMACEUTICALS
UPS, one of the world’ s largest logistics companies with 2023 revenue of US $ 91bn, continues to push forward with its purpose of“ delivering what matters”.
With a workforce of approximately 500,000 employees, the company focuses on being“ Customer First, People Led, Innovation Driven”.
The latest step in this mission is its acquisition of German healthcare logistics firms Frigo-Trans and its sister company BPL, collectively known as Frigo-Trans.
This acquisition, first announced in September 2024, has now been completed, marking a significant expansion of UPS Healthcare’ s capabilities across Europe.
It addresses the growing demand from pharmaceutical and biotech industries for temperature-sensitive and time-critical logistics.
Strategic growth in healthcare logistics The acquisition highlights UPS’ commitment to meeting the complex needs of healthcare customers. With the pharmaceutical industry advancing rapidly, there is increasing reliance on cold and frozen supply chains.
Kate Gutmann, UPS’ s Executive Vice President and President of International, Healthcare and Supply Chain Solutions,
62 April 2025